$WGIH ======.  WGI Holding, Inc Announces That It Has

New Post Public Reply Private Reply Replies (0) Message Board
PsychoStockNoob999

$WGIH ======>>>>>.  WGI Holding, Inc Announces That It Has Declared a Dividend to Its Shareholders!!!!!!

LAS VEGAS, NV -- (Marketwire) -- 03/11/13 -- WGI Holdings, Inc. (OTC Pink: WGIH) -- The Board of Directors of WGI Holdings are pleased to announce that they have declared a dividend of the shares to all the shareholders of record of WGI Holdings on March 15th, 2013 ("Record Date").

The dividend will be equal to 200.0% of the share price at the market close on the Record Date. The dividend is payable in common stock. Each stockholder's dividend will be calculated based on the number of shares owned on the Record Date by the stockholder. The new shares will be issued following the Record Date. The number of shares will equal two (2) shares for each one (1) share owned by the stockholder on the Record Date, rounded upwards to the next whole share.

The class of shares receiving the dividend is the common shares.

The record date of the dividend is March 15th, 2013.

The payment date is March 30th, 2013.

Only shareholders that actually have shares in their names, or in the name of the broker that holds them for them in safekeeping will be eligible.

To ensure you get your dividend shares, you must ensure that if you have purchased shares of WGI Holdings, your broker must have physical delivery of the shares in their possession and proof has to be sent to the transfer agent by the Record Date of March 15th.

Anybody who has purchased shares of our company, you should make sure your broker has received the shares you have purchased in physical form on your behalf and have them in safekeeping, if they do not have them in the firms possession, then you need to insist they get them from the selling broker immediately, otherwise you will not be eligible to receive the dividend.

"This is a terrific payout to our shareholders and we are very pleased with the results for the company," said Kyle Bendford, CTO, MyBitCloud.

About WGI Holdings

WGI Holdings' goal through its operating subsidiary MyBitCloud is to become a leading provider of Personal & Business Cloud services that enable users and organizations to access ALL of their data, anytime, anywhere, and from any supported device.

MyBitCloud will enable users and organizations to have unlimited storage capability while also providing backup, synchronization, access and sharing capability of any file instantly and securely. More information can be found on our website: www.mybitcloud.com

FORWARD-LOOKING DISCLAIMER

This summary contains forward-looking statements within the meaning of the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. These statements address future events and conditions concerning the Company's business plans. Such statements are based on management's current expectation and are subject to a number of factors and uncertainties, such as future economic conditions and changes in anticipated revenues and costs, which may cause actual results to differ materially. The Company expressively disclaims any future obligation or undertaking to update or revise any forward-looking statements contained herein. Investors and potential investors should independently investigate and fully understand all risks before making investment decisions.

 For more information contact us at:
Susan Millstone
MyBitCloud Inc.
Tel: 855-667-8786
FAX: 855-433-4464
 Susan@MyBitCloud.com  

 

Source: WGI Holdings Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Infosys Pushes AI Growth with Strong Deal Wins

Updated Category News Views 17

Riding the AI Wave Who knew Infosys was a lightning rod for AI momentum, eh? With a 29% quarterly surge in AI revenue, the firm's really putting AI strategy at center stage. Considering today's finicky markets, that's not just peanuts. CEO Salil Parekh's swagger is backed by real numbers, seeing AI revenue inch to 10.5% of total haul. This ain't just talk—Infosys is...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 48

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 37

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
SLM Faces Legal Scrutiny as Losses Mount Amid Pause

Updated Category News Views 36

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 30

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 4

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading
Violet PR's Big Wins Hint at Industry Strategies

Updated Category News Views 15

A Shining Night in Morristown Picture Violet PR's team on top of the world, right there in Morristown, getting the accolades every agency dreams of—five awards from PRSA-NJ. It's not just an ego trip, either. This is about setting a high bar in the world of strategic communications, and they're flaunting their ability to drive growth and innovation in the economic...

Continue Reading
BOB Raises $5.5M for AI Banking Platform Revolution

Updated Category News Views 24

Cracking the Code of Small Business Finance BOB, a Miami hotshot aiming to be more than just another fintech flash in the pan, has wrangled a sweet $5.5 million in seed capital. They're shaking hands with big names like Peter Thiel and the mastermind behind Plaid, Zak Perret, through Mischief Ventures. The plan? To build an AI-powered finance savior for small businesses...

Continue Reading
GeeLark's Tech Leap: Expanding Cloud Phone Functions

Updated Category News Views 3

GeeLark's New Frontier GeeLark is kicking up some dust in the tech space by tooling up its cloud phone workflows with an arsenal of new supports: API, CLI, and MCP. This isn't just some minor patch, folks. It's a bold move, and for those in the quicksand of digital operations, a game-changer. You know how much of a drag it is repeating the same setup steps over and over?...

Continue Reading

Top 5 Most Recently Viewed Articles

CoinW Showcases Its Innovations at Taipei Blockchain Week 2024

Updated Category News Views 261

CoinW's Impactful Presence at Taipei Blockchain Week 2024 At the forefront of innovation and security, CoinW, a globally recognized cryptocurrency exchange, recently showcased its vision for the future during Taipei Blockchain Week 2024 as a Gold Sponsor. The event, celebrated for fostering discussions on blockchain advancements, featured the launch of PropW, CoinW's...

Continue Reading
Bank of Åland Plc Seeks Trading Admission of New Covered Bonds

Updated Category News Views 170

Application for Trading Admission of Covered Bonds Bank of Åland Plc, also recognized as Ålandsbanken Abp, is taking an important step by applying for the admission of a new security to trading on Nasdaq Helsinki. This involves their recent issuance of covered bonds, which are highly regarded in the financial market. Details of the Covered Bonds Issue The primary...

Continue Reading
Simpson Manufacturing's Q3 Earnings Report Shows Challenges Ahead

Updated Category News Views 54

Simpson Manufacturing's Third Quarter Performance Simpson Manufacturing Co., Inc. (NYSE: SSD) recently announced its third-quarter earnings, and the results did not meet the expectations of analysts. This disappointing performance resulted in a 5% decline in shares during after-hours trading. The company's focus on producing wood construction products highlights the...

Continue Reading
Alvotech Faces Challenges in Biologics License Approval Process

Updated Category News Views 349

Overview of Biologics License Application Status Alvotech, a prominent biotech firm specializing in biosimilars, has recently updated the market regarding its application status for AVT05, a potential competitor to Simponi (golimumab). The company has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) highlighting certain...

Continue Reading
Replimune Group Faces Class Action Lawsuit Amid FDA Setback

Updated Category News Views 127

Replimune Group Faces Class Action Lawsuit Amid FDA Setback Pomerantz LLP has brought attention to a class action lawsuit involving Replimune Group, Inc. (NASDAQ: REPL). This legal action is relevant for investors who have experienced losses on their investments in the company. It's crucial for affected investors to be proactive and consider their options as they navigate...

Continue Reading